1. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ. (2002). sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. Journal of Bacteriology. 184(19): 5457-67.
2. Shaw L, Golonka E, Potempa J, Foster SJ. (2004). The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology. 150(1): 217-28.
3. Calander AM, Jonsson IM, Kanth A, Arvidsson S, Shaw LN, Foster SJ, Tarkowski A. (2004). Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes and Infection. 6(2): 202-206.
4. Shaw LN, Golonka E, Szmyd G, Foster SJ, Travis J, Potempa J. (2005). Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype. Journal of Bacteriology. 187(5): 1751-1762.
5. Potempa J, Golonka E, Filipek R, Shaw LN. (2005). Fighting an enemy within: cytoplasmic inhibitors of bacterial cysteine proteases. Molecular Microbiology. 57(3): 605-10.
6. Moon J, Shaw LN, Mayo J, Potempa J, Travis J. (2006). Isolation and Properties of Extracellular Proteinases of P. marneffei. Biological Chemistry. 387(7): 985-93.
7. Shaw LN*, Aish J, Davenport JE, Brown, MC, Lithgow JK, Simmonite K, Crossley H, Travis J, Potempa J, Foster SJ. (2006). Investigations into σB–modulated regulatory pathways governing extracellular virulence determinant production in Staphylococcus aureus. Journal of Bacteriology. 188(17): 6070-6080. *Corresponding author.
8. Golonka E, Potempa J, Travis J, Shaw LN. (2006). Poison-antidote systems in bacteria: the co-evolution of functional counterparts. Cellular & Molecular Biology. 52(4): 18-22.
9. Shaw LN, Jonsson IM, Singh VK, Tarkowski A, Stewart GC. (2007). Inactivation of traP has no effect on the agr quorum-sensing system of virulence of Staphylococcus. Infection and Immunity. 75(9): 4519-4527.
10. Kubica M, Guzik K, Koziel J, Zarebski M, Richter W, Gajkowska B, Golda A, Maciag-Gudowska A, Brix K, Shaw L, Foster TJ, Potempa J. (2008). A potential new pathway for Staphylococcus aureus dissemination: The silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One. 3(1):e1409.
11. Lupa B, Lyon D, Shaw LN, Sieprawska-Lupa M, Wiegel J. (2008).Properties of the Reversible Non-oxidative Vanillate / 4-hydroxybenzoateDecarboxylase from Bacillus subtilis and the Corrected Annotation of its Genes. Canadian Journal of Microbiology. 54(1):75-81.
12. Johnson BT, Shaw LN, Nelson D, Mayo JA. (2008). Extracellular proteolytic activities expressed by Bacillus pumilus isolated from endodontic and periodontal lesions. Journal of Medical Microbiology. 57(5):643-651.
13. Tsang LH, Cassat JE, Shaw LN, Beenken KE, Smeltzer MS. (2008). Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS One. 3(10):33361
14. Shaw LN*, Lindholm C, Prajsnar TK, Miller, HK, Brown, MC, Golonka E, Stewart GC, Tarkowski A, Potempa J. (2008). Identification and Characterization of σS, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS ONE. 3(12):e3844. *Corresponding author.
15. Koziel J, Maciag-Gudowska A, Mikolajczyk T, Bzowska M, Sturdevant DE, Whitney AR, Shaw LN, DeLeo FR, Potempa J. (2009). Phagocytosis of Staphylococcus aureus by Macrophages Exerts Cytoprotective Effects Manifested by the Upregulation of Anti-apoptotic Factors. PLoS ONE. 4(4):e5210.
16. Beenken KE, Mrak LN, Griffin LM, Zielinska AK, Shaw LN, Rice KC, Horswill AR, Bayles KW, Smeltzer MS. (2010). Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS ONE. 5(5):e10790.
17. Ishihara K, Wawrzonek K, Shaw LN, Inagaki S, Miyamoto M, Potempa J. (2010). Dentipain, a Streptococcus-pyogenes-IdeS-protease homologue, is a novel virulence factor of Treponema denticola. Biological Chemistry. 391(9): 1047-55.
18. Zielinska A, Beenken KE, Joo HS, Mrak L, Griffin LM, Luong TT, Lee CY, Otto M, Shaw LN, Smeltzer MS. (2011).Defining the Strain-Dependent Impact of the Staphylococcal Accessory Regulator (sarA) on the Alpha Toxin Phenotype of Staphylococcus aureus. Journal of Bacteriology. 193(12): 2948-2958.
19. Kantyka T, Shaw LN, & Potempa J. (2011). Papain-Like Proteases of Staphylococcus aureus. Advances in Experimental Medicine and Biology. 712: 1-14.
20. Kolar SL, Nagarajan, V, Oszmiana A, Rivera FE, Miller HK, Davenport JE, Riordan JT, Potempa J, Barber DS, Koziel J, Elasri MO, Shaw LN. (2011).NsaRS is a Cell-Envelope-Stress Sensing Two-Component System of Staphylococcus aureus. Microbiology. 157(8): 2206-2219.
21. Padhee S, Hu Y, Niu Y, Bai G, Wu H, Costanza F, West L, Harrington L, Shaw LN, Cao C, Cai J. (2011). Non-Hemolytic α-AApeptides as antimicrobial peptidomimetics. Chemical Communications. 47: 9729-9731.
22. Prosen KR, Carroll R, Burda WN, Krute CK, Bhattacharya B, Dao ML, Turos ET, Shaw LN. (2011).The Impact of Fatty Acids on the Antibacterial Properties of N-Thiolated β-Lactams. Bioorganic and Medicinal Chemistry Letters. 21(18): 5293-5.
23. Niu Y, Padhee S, Wu H, Bai G, Harrington L, Burda WN, Shaw LN, Cao C, Cai J. (2011).Identification of γ-AApeptides with potent and broad-spectrum antimicrobial activity. Chemical Communications. 47: 12197-12199.
24. Rivera F, Miller HK, Kolar SL, Stevens SM, Shaw LN. (2012). The Impact of CodY on Virulence Determinant Production in Community-Associated Methicillin Resistant Staphylococcus aureus. Proteomics. 12(2): 263-268.
25. Burda WN, Fields KB, Gill JB, Burt R, Shepherd M, Zhang XP, Shaw LN. (2012). Neutral Metallated and Meso-Substituted Porphyrins as Antimicrobial Agents Against Gram-Positive Pathogens. European Journal of Clinical Microbiology and Infectious Disease. 31(3): 327-335.
26. Beau J, Mahid N, Burda WN, Harrington L, Shaw LN, Mutka T, Kyle DE, Barisic B, Van Olphen A, Baker BJ. (2012). Epigenetic Tailoring for the Production of Anti-infective Cytosporones from the Mangrove Endophyte Leucostoma persoonii. Marine Drugs. 10(4): 762-774.
27. Niu Y, Padhee S, Wu H, Bai G, Harrington L, Burda WN, Shaw LN, Cao C, Cai J. (2012). Lipo-γ-AApeptides as a New Class of Potent and Broad Spectrum Antimicrobial Agents. J Med Chem. 55(8): 4003-4009.
28. Miller HK, Carroll RK, Burda WN, Krute CN, Davenport JE, Shaw LN. (2012). The ECF Sigma Factor, σS, Protects Against Both Cytoplasmic and Intracellular Stresses in Staphylococcus aureus. J Bacteriology. 194(16): 4342-4354.
29. Carroll RK, Robison TM, Rivera FE, Davenport JE, Jonsson IM, Florczyk D, Tarkowski A, Potempa J, Koziel J, Shaw LN. (2012). Identification of an intracellular M17 family leucine aminopeptidase that is required for virulence in Staphylococcus aureus. Microbes & Infection.14(11): 989-999.
30. Cormier R, Burda WN, Harrington L, Edlinger J, Kodigepalli KM, Thomas J, Kapolka R, Roma G, Anderson BE, Turos E, Shaw LN. (2012). Studies on the antimicrobial properties of N-Acylated ciprofloxacins. Bioorganic & Medicinal Chemistry Letters. 22(20): 6513-6520.
31. Kolar SL, Ibarra AJ, Rivera FE, Mootz JM, Davenport JE, Stevens SM, Horswill AR, Shaw LN. (2013).Extracellular Proteases are Key Mediators of S. aureus Virulence via the Global Modulation of Virulence Determinant Stability. Microbiology Open. 2(1): 18-34.
32. Ibarra JA, Perez-Rueda E, Carroll RK, Shaw LN. (2013). Global Analysis of Transcriptional Regulators in Staphylococcus aureus. BMC Genomics. 14(1): 126.
33. Carroll RK, Veillard F, Gagne D, Lindenmuth J, Poreba M, Drag M, Potempa J, Shaw LN. (2013). The Staphylococcus aureus leucine aminopeptidase is localized to the bacterial cytosol and demonstrates a broad substrate range that extends beyond leucine. Biol Chem. 394(6): 791-803.
34. Carroll RK, Burda WN, Roberts JC, Peak KK, Cannons AC, Shaw LN. (2013). Draft genome of strain CBD-635: a Methicillin Resistant Staphylococcus aureus USA100 isolate. Genome Announcements. 1(4): e00491-13.
35. Kenny JG, Moran J, Kolar SL, Ulanov A, Zhong L, Shaw LN, Josefsson E, Horsburgh MJ. (2013). Mannitol Utilisation is Required for Protection of Staphylococcus aureus from Human Skin Antimicrobial Fatty Acids. PLoS ONE. 8(7): e67698.
36. Bionda N, Fleeman RM, Shaw LN, Cudic P. (2013).Effect of Ester to Amide or N-methyl Amide Substitution on Membrane Depolarization and Antibacterial Activity of Novel Cyclic Lipopeptides. ChemMedChem. 8(8): 1394-1402.
37. Mootz JM, Malone CL, Shaw LN, Horswill AR. (2013). Staphopains modulate Staphylococcus aureus biofilm integrity. Infection and Immunity. 81(9): 3227-3238.